Zyvox is effective in the treatment of MRSA infections

Published: 2002-06-28 06:56:00

Updated: 2002-06-28 06:56:00

Phamacia's antibiotic Zyvox is effective in the treatment of MRSA (methicillin-resistant Staphylococcus aureus), according to a recent issue of 'Clinical Infectious Disease' journal with a theme of 'Comparison of efficacy between linezolid and vancomycin injections in the treatment of MRSA infect...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK